Form 4: Madrigal Pharmaceuticals General Counsel Shannon Kelley Reports Stock and Option Grants

Shannon Kelley, General Counsel of Madrigal Pharmaceuticals, reports the acquisition of restricted stock units and stock options.

Summary

• Shannon Kelley, General Counsel of Madrigal Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
• On March 5, 2025, Kelley was granted 3,187 restricted stock units (RSUs) and an option to purchase 5,368 shares of common stock.
• The RSUs vest in four equal installments on March 5 of 2026, 2027, 2028, and 2029, contingent upon continued service with the issuer.
• The stock options vest 25% on March 5, 2026, and then 6.25% every three months thereafter, also contingent upon continued service.
• Following these transactions, Kelley directly owns 10,477 shares of common stock and options to purchase 5,368 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock options and RSUs, which is generally a positive sign of incentivizing key personnel. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs and stock options aligns the General Counsel's interests with those of the shareholders.
• The vesting schedules incentivize continued service with Madrigal Pharmaceuticals.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.

Industry Context

Stock and option grants are a common practice in the pharmaceutical industry to incentivize and retain key personnel, aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices in the pharmaceutical industry.
• Comparable companies like Viking Therapeutics or Intercept Pharmaceuticals also utilize equity-based compensation to incentivize executives.
• The vesting schedules described are typical, with annual or quarterly vesting over a 4-year period being common.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of aligning management's interests with the company's long-term performance.
• Employees may be motivated by the potential for equity ownership.

Key Dates